Comment by danieltillett

Lots of biotech/medical device companies in this class. Historically this has not been a good category to invest in (unless you like to lose money), nor one that is easy to get right. The FDA is a real pain to deal with and trying to "do things that don’t scale" has you end up like Theranos. I do give YC kudos for trying.